Fleeting footprints: finding MRI biomarkers of transient ischaemic attack

Phillip Zhe Sun; Ayata, Cenk; Lo, Eng H.; Sun, Phillip Zhe
January 2017
Brain: A Journal of Neurology;Jan2017, Vol. 140 Issue 1, p8
Academic Journal
journal article
No abstract available.


Related Articles

  • Platelet Function Following Acute Cerebral Ischemia. Smout, Jonathan; Dyker, Alexander; Cleanthis, Marcus; Ford, Gary; Kesteven, Patrick; Stansby, Gererd // Angiology;Jun/Jul2009, Vol. 60 Issue 3, p362 

    Background: Studies have previously identified increased levels of platelet activation following acute ischemic stroke. In order to evaluate new antiplatelet agents and their combinations, there is a need for accurate measures of platelet activation. Methods: Blood was taken from 17 patients...

  • Cardiac troponin T elevation after stroke: The relationships between elevated serum troponin T, stroke location, and prognosis. Yong Bum Kim // Annals of Indian Academy of Neurology;Nov2008 Supplement, Vol. 11, pS164 

    Background: Serum cardiac troponin T (cTnT) is regarded as a specific marker of acute coronary syndrome. However, increased cTnT is sometimes identified in patients with acute ischemic stroke. The aim of the present study was to identify the relationships between elevated serum cTnT and stroke...

  • Association between neuroserpin and molecular markers of brain damage in patients with acute ischemic stroke. Rodríguez-González, Raquel; Sobrino, Tomás; Rodríguez-Yáñez, Manuel; Millán, Mónica; Brea, David; Miranda, Elena; Moldes, Octavio; Pérez, Juan; Lomas, David A; Leira, Rogelio; Dávalos, Antoni; Castillo, José; Rodríguez-González, Raquel; Sobrino, Tomás; Rodríguez-Yáñez, Manuel; Millán, Mónica; Pérez, Juan; Dávalos, Antoni; Castillo, José // Journal of Translational Medicine;2010 Supplement 1, Vol. 9 Issue Suppl 1, p58 

    Background: Neuroserpin has shown neuroprotective effects in animal models of cerebral ischemia and has been associated with functional outcome after ischemic stroke. Our aim was to study whether neuroserpin serum levels could be associated to biomarkers of excitotoxicity,...

  • Differentiating cerebral ischemia from functional neurological symptom disorder: a psychosomatic perspective. Scheidt, Carl E.; Baumann, Kathrin; Katzev, Michael; Reinhard, Matthias; Rauer, Sebastian; Wirsching, Michael; Joos, Andreas // BMC Psychiatry;2014, Vol. 14 Issue 1, p383 

    Background The differential diagnosis of pseudo-neurological symptoms often represents a clinical challenge. The Diagnostic and Statistical Manual of Mental Disorders, DSM-5, made an attempt to improve diagnostic criteria of conversion disorder (functional neurological symptom disorder)....

  • Racing of the Biological Pacemaker. Yu, Han-Gang // Recent Patents on DNA & Gene Sequences;Nov2009, Vol. 3 Issue 3, p193 

    Over the past decade, rapid progress in the molecular studies of cardiac ion channels and stem cells biology has led to efforts to create a biological pacemaker to supplement the widely-used electronic pacemaker. This review focuses on the main concepts of cardiac pacemaker activities in...

  • FOLLOW UP AND OPTIMISATION OF CARDIAC PACING. Roberts, Paul R. // Heart;Sep2005, Vol. 91 Issue 9, p1229 

    This article focuses on the increased use of cardiac pacemakers. Pacemaker implantation is only the initial phase in the lifelong management of the patient with a pacemaker. The challenge of this treatment lies in the comprehensive follow up of the device. As the number of implanted devices...

  • How can we identify the optimal pacing site in the right ventricular septum? A simplified method applicable during the standard implanting procedure. Pastore, Gianni; Zanon, Francesco; Baracca, Enrico; Rigatelli, Gianluca; Corbucci, Giorgio; Mazza, Alberto; Noventa, Franco; Roncon, Loris // American Journal of Cardiovascular Disease;2013, Vol. 3 Issue 4, p264 

    Aims: A short paced (p) QRS duration (d) can be a marker for selecting the most appropriate RV pacing site. Although this could be achieved by continual 12-Lead ECG monitoring, such a technique is not applicable during pacemaker (PM) implantation. The purpose of this study was to validate a...

  • MicroRNAs in Cerebral Ischemia. Yang Wang; Yongting Wang; Guo-Yuan Yang // Stroke Research & Treatment;2013, p1 

    The risk of ischemic stroke increases substantially with age, making it the third leading cause of death and the leading cause of long-term disability in the world. Numerous studies demonstrated that genes, RNAs, and proteins are involved in the occurrence and development of stroke. Current...

  • Visualization of cell death in mice with focal cerebral ischemia using fluorescent annexin A5, propidium iodide, and TUNEL staining. Bahmani, Peyman; Schellenberger, Eyk; Klohs, Jan; Steinbrink, Jens; Cordell, Ryan; Zille, Marietta; M�ller, Jochen; Harhausen, Denise; Hofstra, Leo; Reutelingsperger, Chris; Farr, Tracy Deanne; Dirnagl, Ulrich; Wunder, Andreas // Journal of Cerebral Blood Flow & Metabolism;May2011, Vol. 31 Issue 5, p1311 

    To monitor stroke-induced brain damage and assess neuroprotective therapies, specific imaging of cell death after cerebral ischemia in a noninvasive manner is highly desirable. Annexin A5 has been suggested as a marker for imaging cell death under various disease conditions including stroke. In...


Other Topics